活血化瘀化痰通络法联合西医常规治疗缺血性脑卒中的临床效果分析  

Efficacy of the Huoxue Huayu Huatan Tongluo therapy plus conventional western medicine on ischemic stroke

作　　者：李雁萍 陈文华 付斌 冯可样 陆伟标 Li Yanping

机构地区：[1]佛山市南海区第四人民医院,广东佛山528211

出　　处：《中医临床研究》2020年第10期111-113,共3页Clinical Journal Of Chinese Medicine

摘　　要：目的:研究活血化瘀化痰通络法联合西医常规治疗缺血性脑卒中的临床效果。方法:采用随机对照法,将2017年1月-2019年4月我院收治的缺血性脑卒中痰瘀阻络证患者68例分为对照组和实验组,每组各34例,对照组予以除脱水外的西医常规治疗,实验组在对照组基础上加用自拟的通络化痰汤加减治疗,比较两组治疗后神经功能、血小板参数、临床疗效及不良反应发生率。结果:实验组总有效率高于对照组(P<0.05);实验组美国国立卫生研究院卒中量表评分(National Institutes of Health Stroke Scale,NIHSS)及Ashworth评分均低于对照组(P<0.05);实验组血小板计数与对照组比较差异无统计学意义(P>0.05),但血小板聚集率及血小板体积低于对照组(P<0.05),实验组不良反应发生率低于对照组(P<0.05)。结论:活血化瘀化痰通络法联合西医常规治疗缺血性脑卒中效果明显,不良反应发生率低,值得临床推广。Objective:To investigate efficacy of the Huoxue Huayu Huatan Tongluo therapy(活血化瘀化痰通络法)plus conventional western medicine on ischemic stroke.Methods:From January 2017 to April 2019,68 cases of ischemic stroke of the Tanyu Zuluo syndrome(痰瘀阻络证)were divided into two groups,34 cases in each.The control group was given conventional western medicine other than dehydration,and the experimental group was given the Tongluo Huatan decoction(通络化痰汤)more.Results:In the experimental group,the total efficiency was higher than the control group(P<0.05).NIHSS score and Ashworth score were lower than those in the control group(P<0.05).There was no significant difference in platelet count between two groups(P>0.05).The platelet aggregation rate and platelet volume in the experimental group were lower than the control group(P<0.05).The incidence of adverse reactions in the experimental group was lower than that in the control group(P<0.05).Conclusion:The Huoxue Huayu Huatan Tongluo therapy plus conventional western medicine on ischemic stroke shows good effects,with lower incidence of adverse reactions,and is worthy of clinical promotion.

关 键 词：活血化瘀化痰通络法 缺血性脑卒中 神经功能 痰瘀阻络证 

分 类 号：R255.2[医药卫生—中医内科学]